TW200502250A - Treating androgen decline in aging male (ADAM)-associated conditions with SARMS - Google Patents
Treating androgen decline in aging male (ADAM)-associated conditions with SARMSInfo
- Publication number
- TW200502250A TW200502250A TW092128721A TW92128721A TW200502250A TW 200502250 A TW200502250 A TW 200502250A TW 092128721 A TW092128721 A TW 092128721A TW 92128721 A TW92128721 A TW 92128721A TW 200502250 A TW200502250 A TW 200502250A
- Authority
- TW
- Taiwan
- Prior art keywords
- adam
- subject
- male
- treating
- sarms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41833602P | 2002-10-16 | 2002-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200502250A true TW200502250A (en) | 2005-01-16 |
Family
ID=32107914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092128721A TW200502250A (en) | 2002-10-16 | 2003-10-16 | Treating androgen decline in aging male (ADAM)-associated conditions with SARMS |
Country Status (9)
Country | Link |
---|---|
US (1) | US20050080054A1 (zh) |
EP (1) | EP1558233A2 (zh) |
JP (1) | JP2006505564A (zh) |
CN (1) | CN1726020A (zh) |
AU (1) | AU2003287079A1 (zh) |
CA (1) | CA2501874A1 (zh) |
IL (1) | IL168046A0 (zh) |
TW (1) | TW200502250A (zh) |
WO (1) | WO2004035739A2 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8445534B2 (en) | 2000-08-24 | 2013-05-21 | University Of Tennessee Research Foundation | Treating androgen decline in aging male (ADAM)-associated conditions with SARMs |
US20060276539A1 (en) * | 2002-10-16 | 2006-12-07 | Dalton James T | Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS |
US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
FI20030958A0 (fi) * | 2003-06-27 | 2003-06-27 | Orion Corp | Uusia yhdisteitä |
JP2007508386A (ja) * | 2003-10-14 | 2007-04-05 | ジーティーエックス・インコーポレイテッド | 選択的アンドロゲン受容体調節剤による骨関連疾患の治療 |
KR20070057792A (ko) | 2004-07-16 | 2007-06-07 | 선에시스 파마슈티컬스 인코포레이티드 | 오로라 키나아제 저해물질로서 유용한 티에노피리미딘 |
EP1945224B1 (en) | 2005-10-19 | 2012-05-02 | Chavah Pty Ltd | Reduction of side effects from aromatase inhibitors used for treating breast cancer |
US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US10010521B2 (en) | 2006-08-24 | 2018-07-03 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
RU2012134351A (ru) | 2010-01-11 | 2014-02-20 | ДЖиТиЭкс, ИНК. | Способы лечения дисфункции мейбомиевых желез |
JP6055215B2 (ja) | 2012-06-29 | 2016-12-27 | キーサイト テクノロジーズ, インク. | インピーダンス測定方法及び測定装置 |
CN113633644A (zh) | 2014-10-22 | 2021-11-12 | 哈瓦赫治疗有限公司 | 降低乳房摄影乳腺密度和/或乳腺癌风险的方法 |
JP2018534291A (ja) | 2015-10-22 | 2018-11-22 | ハバフ セラピューティクス ピーティーワイ エルティーディー | マンモグラフィ乳房密度及び/又は乳癌のリスクを低下させる方法 |
EP3976048A4 (en) | 2019-06-03 | 2023-07-12 | Havah Therapeutics Pty Ltd | PHARMACEUTICAL FORMULATIONS AND SYSTEMS FOR THE ADMINISTRATION OF AN ANDROGEN AGENT AND AN AROMATASE INHIBITOR, AND METHODS OF USE |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3875229A (en) * | 1972-11-24 | 1975-04-01 | Schering Corp | Substituted carboxanilides |
US4139638A (en) * | 1976-09-23 | 1979-02-13 | Schering Corporation | Methods for the treatment of hirsutism |
EP0002309B1 (en) * | 1977-10-12 | 1982-12-01 | Imperial Chemical Industries Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
US4191775A (en) * | 1977-12-15 | 1980-03-04 | Imperial Chemical Industries Limited | Amide derivatives |
NZ197008A (en) * | 1980-05-22 | 1984-10-19 | Ici Ltd | Acylanilide derivatives and pharmaceutical compositions |
JPS57171904A (en) * | 1981-04-15 | 1982-10-22 | Mitsubishi Petrochem Co Ltd | Tri- or tetra-substituted phenoxycarboxylic acid anilide type herbicide |
DE3372965D1 (en) * | 1982-07-23 | 1987-09-17 | Ici Plc | Amide derivatives |
GB8617652D0 (en) * | 1986-07-18 | 1986-08-28 | Ici Plc | Acylanilide derivatives |
US5162504A (en) * | 1988-06-03 | 1992-11-10 | Cytogen Corporation | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
US5656651A (en) * | 1995-06-16 | 1997-08-12 | Biophysica Inc. | Androgenic directed compositions |
US6017924A (en) * | 1996-06-27 | 2000-01-25 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
US6071957A (en) * | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
WO1998053826A1 (en) * | 1997-05-30 | 1998-12-03 | The University Of Tennessee Research Corporation | Non-steroidal agonist compounds and their use in male hormone therapy |
AU7723198A (en) * | 1997-06-04 | 1998-12-21 | University Of Tennessee Research Corporation, The | Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging |
IL154425A0 (en) * | 2000-08-24 | 2003-09-17 | Univ Tennessee Res H Corp | Selective androgen receptor modulators and methods of use thereof |
US8008348B2 (en) * | 2001-12-06 | 2011-08-30 | University Of Tennessee Research Foundation | Treating muscle wasting with selective androgen receptor modulators |
US7645898B2 (en) * | 2000-08-24 | 2010-01-12 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and method of use thereof |
US7026500B2 (en) * | 2000-08-24 | 2006-04-11 | University Of Tennessee Research Foundation | Halogenated selective androgen receptor modulators and methods of use thereof |
PT1401801E (pt) * | 2000-08-24 | 2007-02-28 | Univ Tennessee Res Foundation | Modulares selectivos de receptor de androgénio e métodos para a sua utilização |
MXPA04005519A (es) * | 2001-12-06 | 2005-06-20 | Gtx Inc | Tratamiento del desgaste muscular con moduladores receptores de androgeno selectivos. |
US20070161608A1 (en) * | 2001-12-06 | 2007-07-12 | Dalton James T | Selective androgen receptor modulators for treating muscle wasting |
RS69704A (en) * | 2002-02-07 | 2006-12-15 | Gtx Inc. | Treating bening prostate hyperplasia with sarms |
US20040224979A1 (en) * | 2002-10-15 | 2004-11-11 | Dalton James T. | Treating obesity with selective androgen receptor modulators |
AU2004206909A1 (en) * | 2003-01-22 | 2004-08-05 | Gtx Inc. | Treating androgen deficiency in female (ADIF)-associated conditions with sarms |
JP2007508386A (ja) * | 2003-10-14 | 2007-04-05 | ジーティーエックス・インコーポレイテッド | 選択的アンドロゲン受容体調節剤による骨関連疾患の治療 |
EP1931199A4 (en) * | 2005-08-31 | 2009-07-29 | Univ Tennessee Res Foundation | TREATMENT OF RENAL DISEASE, BURNS, INJURIES OR SPINAL CORD INJURY USING ANDROGEN RECEPTOR SELECTIVE MODULATORS |
-
2003
- 2003-10-14 JP JP2004544891A patent/JP2006505564A/ja active Pending
- 2003-10-14 CA CA002501874A patent/CA2501874A1/en not_active Abandoned
- 2003-10-14 WO PCT/US2003/032513 patent/WO2004035739A2/en active Application Filing
- 2003-10-14 US US10/683,161 patent/US20050080054A1/en not_active Abandoned
- 2003-10-14 CN CNA2003801063099A patent/CN1726020A/zh active Pending
- 2003-10-14 AU AU2003287079A patent/AU2003287079A1/en not_active Abandoned
- 2003-10-14 EP EP03777600A patent/EP1558233A2/en not_active Withdrawn
- 2003-10-16 TW TW092128721A patent/TW200502250A/zh unknown
-
2005
- 2005-04-14 IL IL168046A patent/IL168046A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004035739A3 (en) | 2004-09-30 |
EP1558233A2 (en) | 2005-08-03 |
US20050080054A1 (en) | 2005-04-14 |
AU2003287079A1 (en) | 2004-05-04 |
CN1726020A (zh) | 2006-01-25 |
CA2501874A1 (en) | 2004-04-29 |
JP2006505564A (ja) | 2006-02-16 |
WO2004035739A2 (en) | 2004-04-29 |
IL168046A0 (en) | 2009-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200503729A (en) | Treating androgen deficiency in female (ADIF)-associated conditions with SARMS | |
TW200502250A (en) | Treating androgen decline in aging male (ADAM)-associated conditions with SARMS | |
WO2004035736A3 (en) | Halogenated selective androgen receptor modulators and methods of use thereof | |
TW200407280A (en) | N-bridged selective androgen receptor modulators and methods of use thereof | |
EP1487458A4 (en) | MULTIPLE SUBSTITUTED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHOD OF USE THEREOF | |
WO2004035737A3 (en) | Heterocyclic selective androgen receptor modulators and methods of use thereof | |
WO2004035738A3 (en) | Methylene-bridged selective androgen receptor modulators and methods of use thereof | |
WO2003074449A3 (en) | Multi-substitued selective androgen receptor modulators and methods of use thereof | |
TW200613252A (en) | Metabolites of selective androgen receptor modulators and methods of use thereof | |
HK1068103A1 (en) | Selective androgen receptor modulators (sarms) for treating benign prostate hyperplasia | |
NO20084114L (no) | Selektive androgenreseptormodulatorer | |
WO2003074473A3 (en) | Irreversible selective androgen receptor modulators and methods of use thereof | |
SI1902026T1 (sl) | Derivati tetrahidrokarbazola uporabni kot modulatorji androgenskega receptorja | |
WO2004062612A3 (en) | Large-scale synthesis of selective androgen receptor modulators | |
WO2007126988A3 (en) | Selective androgen receptor modulators and methods of use thereof | |
PL1891038T3 (pl) | Podstawione n-arylopirolidyny jako selektywne modulatory receptora androgenowego | |
GEP20135925B (en) | Inhibitors of hedgehog pathway | |
WO2003049675A3 (en) | Treating muscle wasting with selective androgen receptor modulators | |
EP1491524A3 (en) | Selective androgen receptor modulators and methods of use thereof | |
WO2009011893A3 (en) | Treatments of b-cell proliferative disorders | |
WO2007081696A3 (en) | Treating androgen decline in aging male (adam)-associated conditions with sarms | |
GB0221539D0 (en) | Methods of treatment | |
TW200512204A (en) | A method of treating breast cancer with androgen receptor antagonists | |
MXPA05005337A (es) | Uso de moduladores de receptor de progesterona selectivos para el tratamiento de deficiencia de androgenos. |